PALI — PALISADE BIO INC

Ownership history in Commodore Capital LP  ·  1 quarter on record

This page tracks every 13F SEC filing in which Commodore Capital LP reported a position in PALISADE BIO INC (PALI). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
1.79% (2025 Q4)
Avg. % of fund
1.79%
First filed
2025 Q4
Last filed
2025 Q4
Quarters held
1
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 INITIATED 11,445,000 — — 1.79% $26.9M $2.35
% of Fund (quarterly)    PALI price (monthly, adj. close)

Other funds also holding PALI

As of 2025 Q4 — sorted by position size

B Group, Inc. 7.81% Octagon Capital Advisors LP 3Y 2.73% STEMPOINT CAPITAL LP 1.69% Exome Asset Management LLC 0.85% HighVista Strategies LLC 3Y 7Y 0.79% Artia Global Partners LP 3Y 0.66% Eversept Partners, LP 3Y 7Y 0.64% Seven Fleet Capital Management LP 0.59% PERCEPTIVE ADVISORS LLC 3Y 7Y 0.5% SUPERSTRING CAPITAL MANAGEMENT LP 0.46%
← Back to Commodore Capital LP Holdings